Cargando…

Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation

AIMS: Undetected atrial fibrillation (AF) is a major health concern. Blood biomarkers associated with AF could simplify patient selection for screening and further inform ongoing research towards stratified prevention and treatment of AF. METHODS AND RESULTS: Forty common cardiovascular biomarkers w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chua, Winnie, Purmah, Yanish, Cardoso, Victor R, Gkoutos, Georgios V, Tull, Samantha P, Neculau, Georgiana, Thomas, Mark R, Kotecha, Dipak, Lip, Gregory Y H, Kirchhof, Paulus, Fabritz, Larissa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475521/ https://www.ncbi.nlm.nih.gov/pubmed/30615112 http://dx.doi.org/10.1093/eurheartj/ehy815

Ejemplares similares

Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study
por: Chua, Winnie, et al.
Publicado: (2021)

Detection of unknown atrial fibrillation by prolonged ECG monitoring in an all-comer patient cohort and association with clinical and Holter variables
por: Jawad-Ul-Qamar, Muhammad, et al.
Publicado: (2020)

Prognostic models for predicting incident or recurrent atrial fibrillation: protocol for a systematic review
por: Dretzke, Janine, et al.
Publicado: (2019)

Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death
por: Brady, Paul F., et al.
Publicado: (2022)

European Society of Cardiology smartphone and tablet applications for patients with atrial fibrillation and their health care providers
por: Kotecha, Dipak, et al.
Publicado: (2018)

Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models
por: Dretzke, Janine, et al.
Publicado: (2020)

Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank
por: Kany, Shinwan, et al.
Publicado: (2022)

An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions
por: Chua, Winnie, et al.
Publicado: (2023)

Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe
por: Schnabel, Renate B., et al.
Publicado: (2018)

PITX2‐dependent gene regulation in atrial fibrillation and rhythm control
por: Syeda, Fahima, et al.
Publicado: (2017)

An Introduction to Murine Models of Atrial Fibrillation
por: Riley, Genna, et al.
Publicado: (2012)

Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation
por: Reyat, Jasmeet S., et al.
Publicado: (2020)

The RACE-3 is on: double-locking sinus rhythm by upstream and downstream therapy
por: Pavlovic, Davor, et al.
Publicado: (2018)

Improving the diagnosis of heart failure in patients with atrial fibrillation
por: Bunting, Karina V, et al.
Publicado: (2021)

Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5
por: Kloosterman, Mariëlle, et al.
Publicado: (2020)

Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial
por: Kirchhof, Paulus, et al.
Publicado: (2020)

A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial
por: Kotecha, Dipak, et al.
Publicado: (2017)

Post-mortem examination of high mortality in patients with heart failure and atrial fibrillation
por: Țica, Otilia, et al.
Publicado: (2022)

Development and external validation of predictive models for prevalent and recurrent atrial fibrillation: a protocol for the analysis of the CATCH ME combined dataset
por: Chua, Winnie, et al.
Publicado: (2019)

Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation
por: Schnabel, Renate B, et al.
Publicado: (2017)

Integrated care of patients with atrial fibrillation: the 2016 ESC atrial fibrillation guidelines
por: Kirchhof, Paulus
Publicado: (2017)

A Regional Reduction in I(to) and I(KACh) in the Murine Posterior Left Atrial Myocardium Is Associated with Action Potential Prolongation and Increased Ectopic Activity
por: Holmes, Andrew P., et al.
Publicado: (2016)

Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care
por: Lane, Deirdre A., et al.
Publicado: (2017)

Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis
por: Gill, Simrat, et al.
Publicado: (2022)

Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data
por: Ziff, Oliver J, et al.
Publicado: (2015)

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
por: Rohla, Miklos, et al.
Publicado: (2019)

Catheter ablation in patients with persistent atrial fibrillation
por: Kirchhof, Paulus, et al.
Publicado: (2017)

PITX2 Modulates Atrial Membrane Potential and the Antiarrhythmic Effects of Sodium-Channel Blockers
por: Syeda, Fahima, et al.
Publicado: (2016)

Almanac 2015: atrial fibrillation research in Heart
por: Jawad-Ul-Qamar, Muhammad, et al.
Publicado: (2016)

Recent advances in rhythm control for atrial fibrillation
por: Bond, Richard, et al.
Publicado: (2017)

Self-palpation for detection of paroxysmal atrial fibrillation: Much noise with little signal
por: Rahimi, Kazem, et al.
Publicado: (2020)

Atrial fibrillation in heart failure: what should we do?
por: Kotecha, Dipak, et al.
Publicado: (2015)

An automated system using spatial oversampling for optical mapping in murine atria. Development and validation with monophasic and transmembrane action potentials
por: Yu, Ting Yue, et al.
Publicado: (2014)

Biomarkers Associated With Aortic Valve Calcification: Should We Focus on Sex Specific Processes?
por: Peeters, Frederique E. C. M., et al.
Publicado: (2020)

Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy
por: Law, Jonathan P., et al.
Publicado: (2020)

Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial
por: Kany, Shinwan, et al.
Publicado: (2023)

Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
por: Ţica, Otilia, et al.
Publicado: (2022)

LMNA Mutation in a Family with a Strong History of Sudden Cardiac Death
por: Keil, Laura, et al.
Publicado: (2022)

Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis
por: Karwath, Andreas, et al.
Publicado: (2021)

Spironolactone in Atrial Fibrillation With Preserved Cardiac Fraction: The IMPRESS‐AF Trial
por: Shantsila, Eduard, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_82bq7l8ncat28ore43d61tmo94